Hence, the level of ILA and related 2-hydroxyacids seems to be actively controlled and does not appear to be a side-reaction of a constrained BCAA degradation like that in maple syrup urine disease (Maksym et al., 2018). This evidence concerns the gene TNFRSF9 and maple syrup urine disease.